Control
Dietary SupplementMaltodextrin (generic) in powder form, flavoured and instantised to be dissolved in water.
Other names: MALTODEXTRIN
NCT Number: NCT02529124
The focus is healthy ageing, i.e. delaying the deterioration in health status in older adults. Loss of lean tissue (skeletal muscle) mass, a process termed sarcopenia, or bone tissue mass, a process called osteopenia, is a consequence of aging per se, modified by nutrition and lifestyle behaviour.
The aim is to conduct a study of body composition, physical activity, muscle function and ability to undertake activities of daily living in older Irish men and women and to investigate the effect of a six month period of nutrient support, or nutrient plus physical activity on lean tissue mass and function and bone mass in men and women aged 50 to 70 years.
Looking for future studies?
Notify Me50 year–70 year
All sexes
Interventional
Not applicable
Study Design: The study is a convenience population study and 6-month randomised control trial (RCT) of men and women age 55 to 70 years.
The study groups (n=60 per group) for the RCT are:
Subject recruitment: Men and women, age 50 to 70 years, will be recruited through the UL Body Composition Study, by email advertisement, GP-exercise referral scheme, feature article(s) in the local media and word of mouth.
Requirement of the participants.
On entry each subject will undertake a preliminary assessment as follows:
i. medical history and examination by a qualified medical doctor ; ii. provide a blood and urine sample to be evaluated by a qualified medical doctor; iii. food intake evaluated by a qualified dietician; iv. whole body and segmental body composition analysis (DXA); v. habitual physical activity level (PAL) vi. measurement of muscle function and performance in simulated activities of daily living.
One month following the preliminary assessment subjects will be invited to participate in a 6 month intervention programme of nutrient or nutrient plus physical activity. Consenting subjects will be randomly assigned to one of the three study groups stated above.
Upon completion (6 months), subjects will be re-assessed as follows; i. provide a blood and urine sample; ii. whole body and segmental body composition analysis (DXA); iii. measurement of muscle function and performance in simulated activities of daily living.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Maltodextrin (generic) in powder form, flavoured and instantised to be dissolved in water.
Other names: MALTODEXTRIN
The milk protein matrix (PROTEIN) comprised a 9:2:1 ratio of milk protein concentrate (MPC, 80% (w/w protein) Glanbia Nutritionals, Kilkenny, Ireland), whey protein concentrate hydrolysate, degree of hydrolysis 32% (WPC DH 32, 78% (w/w protein) Carbery Ingredients, Ballineen, Ireland), whey protein isolate hydrolysate, degree of hydrolysis 45% (WPI DH 45, 75% (w/w protein) Glanbia Nutritionals). The total protein content was 72.7g/100g powder. The protein matrix was supplemented with 2187mg/100g powder of milk-based calcium (Trucal™, Glanbia) and 57.3mg/100g powder vitamin D3 (cholecalciferol), flavoured and instantised to be dissolved in water.
Other names: MILK PROTEIN MATRIX (MPM)
A structured, progressive programme of exercises using resistance exercise bands supervised by clinical therapists undertaken three times per week for 24 weeks of the intervention.
Other names: PA
Time frame: Change from baseline in Lean Tissue Mass at 6 months
Body lean tissue mass measured by dual energy x-ray absorptiometry
Time frame: Change from baseline in Bone Mineral Density at 6 months
Site specific (Lumbar Spine and Femoral Neck) bone mineral density measured by dual energy x-ray absorptiometry
Time frame: Change from baseline in Muscle Function at 6 months
Maximal voluntary contraction (MVC) in Nm (force in Newtons, distance in metres) torque of the knee extensors measured by ergometry will be used to assess Muscle Function.
Time frame: Change from baseline in Muscle Function at 6 months
Rate of force development (RFD) in Nm/s (force in Newtons, distance in metres, time in seconds) torque of the knee extensors measured by ergometry will be used to assess Muscle Function.
Time frame: Change from baseline in Activities of Daily Living at 6 months
The number of completed Chair Rise (i.e. rise from a seated to a standing position) in 30 seconds will be used to assess Activities of Daily Living
Time frame: Change from baseline in Activities of Daily Living at 6 months
The time (time in seconds) to complete 1000 metres (distance in metres) performed in a indoor track will be used to assess Activities of Daily Living
Phil Jakeman
Other
An Investigation of the the Effect of Nutrient Support, or Nutrient Plus Physical Activity on Musculoskeletal Health and Function in Men and Women Aged 55 to 70 Years
Acronym: BCHA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01296776
Atrophy, Behavior
Erlangen, Germany
View Trial DetailsNCT04021706
Atrophy, Bone Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT03453463
Atrophy, Bone Diseases
Erlangen, Germany
View Trial DetailsNCT04288401
Atrophy, Body Weight
Istanbul, Turkey (Türkiye)
View Trial Details